The global Ophthalmoplegia Market is expected to grow at a CAGR of 7.12% from 2017 to 2025.
Ophthalmoplegia is the paralysis or weakness of the eye muscles. It can affect one or more of the six muscles that hold the eye in place and control its movement. Rising geriatric population and increasing healthcare awareness and concerns are some of the factors driving the market.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing geriatric population
1.2 Rising number of diseases including strokes, thyroid disease, brain tumor
1.3 Increasing prevalence of eye sight affecting diseases
2. Market Restraints
2.1 High Cost of Treatment
Market Segmentation:
1. Global Ophthalmoplegia Market, by Type:
1.1 external Ophthalmoplegia
1.2 internuclear Ophthalmoplegia
2. Global Ophthalmoplegia Market, by Treatment:
2.1 surgery
2.2 drug treatment
3. Global Ophthalmoplegia Market, by End User:
3.1 hospitals
3.2 clinics
3.3 ambulatory centers
4. Global Ophthalmoplegia Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Abbott
2. Novartis AG
3. ZEISS International
4. Valeant, Amritt, Inc.
5. Medline Industries, Inc.
6. ALLERGAN
7. Johnson & Johnson Private Limited
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Ophthalmoplegia Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
Price : US$ 3500 | Date : Mar 2023 |
Category : Healthcare and Pharmaceuticals | Pages : 142 |
Price : US$ 3500 | Date : Feb 2021 |
Category : Healthcare and Pharmaceuticals | Pages : 151 |
We will be happy to help you find what you need. Please call us or write to us: